{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:22:19Z","timestamp":1777342939180,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.det.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T09:47:35Z","timestamp":1221558455000},"page":"569-578","source":"Crossref","is-referenced-by-count":35,"title":["Lipodystrophy Syndromes"],"prefix":"10.1016","volume":"26","author":[{"given":"Pedro","family":"Herranz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"de Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"P\u00e9rez-Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matias","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.det.2008.05.004_bib2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2008.05.004_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-133-4-200008150-00017","article-title":"Lipoatrophy, lipodistrophy and insulin resistance","volume":"133","author":"Ganda","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2008.05.004_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.det.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: a report of two cases","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2008.05.004_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb17558.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.det.2008.05.004_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.75.2.358","article-title":"Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy","volume":"75","author":"Garg","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.det.2008.05.004_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","article-title":"Generalized lipodistrophy, congenital and acquired (lipoatrophy)","volume":"413","author":"Seip","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.det.2008.05.004_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2337\/diacare.19.1.28","article-title":"Severe islet amyloidosis in congenital generalized lipodystrophy","volume":"19","author":"Garg","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.det.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotipic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2008.05.004_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.det.2008.05.004_bib13","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lypodistrophy","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2008.05.004_bib14","first-page":"33","article-title":"Familial lipoatrophic diabetes with dominant transmission: a new syndrome","volume":"43","author":"Dunnigan","year":"1974","journal-title":"Q J Med"},{"key":"10.1016\/j.det.2008.05.004_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analysis of families with familial partial lipodystrophy (Duningan variety) reveal recurrent missense mutations in the globular C-terminal of lamin A\/C","volume":"66","author":"Speckman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2008.05.004_bib16","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1210\/jc.85.5.1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2008.05.004_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","article-title":"Localization for the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22","volume":"18","author":"Peters","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.det.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","article-title":"Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy","volume":"49","author":"Vigouroux","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.det.2008.05.004_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.59.4.620","article-title":"Lamin A\/C mutations with lipodystrophy, cardiac abnormalities and muscular dystrophy","volume":"59","author":"Van der Kooi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.det.2008.05.004_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.87.1.408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2008.05.004_bib22","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","article-title":"Kobberling type of familial partial lipodystrophy: an underrecognized syndrome","volume":"26","author":"Herbst","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.det.2008.05.004_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/jc.87.2.776","article-title":"Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associate with mandibuloacral dysplasia","volume":"87","author":"Simha","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2008.05.004_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C","volume":"71","author":"Novelli","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2008.05.004_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.det.2008.05.004_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0190-9622(90)70042-G","article-title":"Systemic lupus erythematosus in a patient with partial lipodystrophy","volume":"22","author":"Font","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib27","first-page":"610","article-title":"Lipodystrophyin patients with juvenile dermatomyositis: evaluation of clinical and metabolic abnormalities","volume":"28","author":"Huermer","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.det.2008.05.004_bib28","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/archderm.1991.04520010088019","article-title":"Partial lipodystrophy associated with juvenile dermatomyositis","volume":"127","author":"Quecedo","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2230.2000.00641.x","article-title":"Barraquer-Simmonds lipodystrophy, Raynaud phenomenon and cutaneous vasculitis","volume":"25","author":"Porter","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib30","first-page":"1083","article-title":"Lipodystrophy de Barraquer et Simmonds anomalies compl\u00e9mentaires et vasculite leucocytoclasique cutan\u00e9e","volume":"114","author":"Perrot","year":"1987","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2008.05.004_bib31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/S0190-9622(03)00789-8","article-title":"Barraquer-Simmonds lipodystrophy associated with antiphospholipid syndrome","volume":"49","author":"Requena","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1471-4914(01)01930-X","article-title":"Molecular basis of partial lipodystrophy and prospects for therapy","volume":"7","author":"Hegele","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.det.2008.05.004_bib33","first-page":"425","article-title":"Identification of nephritic factor as an immunoglobulin","volume":"33","author":"Williams","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.det.2008.05.004_bib34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0272-6386(12)81069-9","article-title":"Are nephritic factors nephrithogenic?","volume":"24","author":"Mathieson","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.det.2008.05.004_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced HIV infection: outpatient study investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2008.05.004_bib36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.det.2008.05.004_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib38","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodistrophy","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00042560-200112150-00006","article-title":"Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection","volume":"8","author":"Ammassari","year":"2001","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.det.2008.05.004_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.det.2008.05.004_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00126334-199907010-00005","article-title":"Insulin resistance in HIV protease inhibitor-associated diabetes","volume":"21","author":"Yarasheki","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.det.2008.05.004_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1568006054553444","article-title":"Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy","volume":"5","author":"Barbaro","year":"2005","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"10.1016\/j.det.2008.05.004_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0190-9622(00)90021-5","article-title":"Protease inhibitor-associated angiolipomatosis","volume":"42","author":"Dank","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocyte targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations","volume":"9","author":"Gougeon","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.det.2008.05.004_bib45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.det.2008.05.004_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1 infected patients","volume":"32","author":"Liechtenstein","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.det.2008.05.004_bib47","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1 infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib48","first-page":"726","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study","volume":"361","author":"HIV Lipodistrophy Case Definition Study Group","year":"2002","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.det.2008.05.004_bib49","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00126334-200212153-00011","article-title":"Relationship between HAART adherence and adipose tissue alterations","volume":"31","author":"Amassari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.det.2008.05.004_bib50","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/00002030-200012220-00007","article-title":"Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure","volume":"14","author":"Miller","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib51","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1524-4725.2002.02099.x","article-title":"HIV-associated facial lipoatrophy","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2008.05.004_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.2005.02049.x","article-title":"Lipoatrophic panniculitis of the ankles","volume":"31","author":"Madasseri","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib53","first-page":"310","article-title":"Insulin induced lipoatrophy","volume":"69","author":"Kshiteendra","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2008.05.004_bib54","first-page":"40","article-title":"Local lipohypertrophy in insulin treatment","volume":"44","author":"Herold","year":"1993","journal-title":"Hautarzt"},{"key":"10.1016\/j.det.2008.05.004_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3476(96)70208-1","article-title":"Semicircular lipoatrophy after intragluteal injection of benzathine penicillin","volume":"129","author":"Kayikeoglu","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.det.2008.05.004_bib56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1525-1470.2002.00201.x","article-title":"Semicircular lipoatrophy in a child with systemic lupus erythematosus after subcutaneous injections of methotrexate","volume":"19","author":"Haas","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1468-3083.2005.01092.x","article-title":"A new case of semicircular lipoatrophy associated with repeated external microtraumas and review of the literature","volume":"19","author":"Gomez-Espejo","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2008.05.004_bib58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2230.2001.00812.x","article-title":"Lipoatrophy semicircularis induced by trauma","volume":"26","author":"Gruber","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(89)70053-0","article-title":"Annular and semicircular lipoatrophies: report of three cases and review of the literature","volume":"20","author":"Rongioletti","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archderm.1971.04000210065012","article-title":"Lipodystrophia centrifugalis abdominalis infantilis","volume":"104","author":"Imamura","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib61","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (Newfill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection","volume":"5","author":"Brown","year":"2004","journal-title":"HIV Med"},{"key":"10.1016\/j.det.2008.05.004_bib63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1524-4725.2002.02832.x","article-title":"3D in-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology","volume":"28","author":"Friedman","year":"2002","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.det.2008.05.004_bib64","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1524-4725.2006.32230.x","article-title":"Full scope of effect of facial lipoatrophy: a framework of disease understanding","volume":"32","author":"Ascher","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2008.05.004_bib65","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.det.2008.05.004_bib66","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2008.05.004_bib67","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0140-6736(99)01172-1","article-title":"Liposuction for protease-inhibitor associated lipodystrophy","volume":"353","author":"Ponce-de-Leon","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.det.2008.05.004_bib68","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.det.2008.05.004_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/135965350300800507","article-title":"Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors","volume":"8","author":"Mart\u00ednez","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1016\/j.det.2008.05.004_bib70","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00002030-199907300-00015","article-title":"A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat distribution","volume":"13","author":"Roubenoff","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib71","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMoa021589","article-title":"Substitution of nevirapine, efavirenz or abacavir for protease inhibitors in patients with HIV infection","volume":"349","author":"Martinez","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1016\/j.det.2008.05.004_bib72","unstructured":"Milinkovic A, Lopez S, Vidal S, et al. A randomized open study comparing the effect of reducing stavudine dose vs switching to tenofovir on mitochondrial function, metabolic parameters, and subcutaneous fat in HIV-infected patients receiving antiretroviral therapy containing stavudin [abstract 857]. 12th Annual\u00a0Conference on Retroviruses and Opportunistic Infections. Boston, February 22\u201325, 2005."},{"key":"10.1016\/j.det.2008.05.004_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00126334-200501010-00009","article-title":"Lopinavir\/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study)","volume":"38","author":"Negredo","year":"2005","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.det.2008.05.004_bib74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00002030-200402200-00010","article-title":"Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial","volume":"18","author":"Maggiolo","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.det.2008.05.004_bib75","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.PRS.0000128427.54445.63","article-title":"Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection","volume":"114","author":"Serra-Renom","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.det.2008.05.004_bib76","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1524-4725.2006.32303.x","article-title":"Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience","volume":"32","author":"Mest","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2008.05.004_bib77","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-L-lactic for the treatment of HIV-associated facial lipoatrophy","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2008.05.004_bib78","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1524-4725.2006.32164.x","article-title":"Use of a biopolymer polyalkylimide filler for facial lipodistrophy in HIV-positive patients undergoing treatment with antiretroviral drugs","volume":"32","author":"Treacy","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2008.05.004_bib79","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0094-1298(20)32763-2","article-title":"Liquid injectable silicone: techniques for soft tissue augmentation","volume":"27","author":"Orentreich","year":"2000","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.det.2008.05.004_bib80","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1524-4725.2006.32256.x","article-title":"Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres","volume":"32","author":"Roy","year":"2006","journal-title":"Dermatol Surg"},{"issue":"Suppl","key":"10.1016\/j.det.2008.05.004_bib81","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1097\/01.prs.0000234847.36020.52","article-title":"Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability","volume":"118","author":"Silvers","year":"2006","journal-title":"Plast Reconstr Surg"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863508000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863508000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:41:03Z","timestamp":1684539663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863508000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0733863508000429"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2008.05.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}